| Year |
Citation |
Score |
| 2021 |
Moharil P, Wan Z, Pardeshi A, Li J, Huang H, Luo Z, Rathod S, Zhang Z, Chen Y, Zhang B, Fernandez CA, Sun J, Li S. Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages. Acta Pharmaceutica Sinica. B. 12: 1148-1162. PMID 35530140 DOI: 10.1016/j.apsb.2021.09.024 |
0.326 |
|
| 2021 |
Xi Y, Li Y, Xu P, Li S, Liu Z, Tung HC, Cai X, Wang J, Huang H, Wang M, Xu M, Ren S, Li S, Zhang M, Lee YJ, et al. The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1. Science Advances. 7: eabg9241. PMID 34516906 DOI: 10.1126/sciadv.abg9241 |
0.605 |
|
| 2020 |
Ma W, Sun J, Xu J, Luo Z, Diao D, Zhang Z, Oberly PJ, Minnigh MB, Xie W, Poloyac SM, Huang Y, Li S. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier. Theranostics. 10: 2463-2478. PMID 32194813 DOI: 10.7150/Thno.38973 |
0.391 |
|
| 2020 |
Sun J, Wan Z, Chen Y, Xu J, Luo Z, Parise RA, Diao D, Ren P, Beumer JH, Lu B, Li S. Triple Drugs Co-Delivered by a Small Gemcitabine-Based Carrier for Pancreatic Cancer Immunochemotherapy. Acta Biomaterialia. PMID 32004652 DOI: 10.1016/J.Actbio.2020.01.039 |
0.369 |
|
| 2020 |
Luo Z, Xu J, Sun J, Huang H, Zhang Z, Ma W, Wan Z, Liu Y, Pardeshi A, Li S. Co-delivery of 2-Deoxyglucose and a Glutamine Metabolism Inhibitor V9302 via a Prodrug Micellar Formulation for Synergistic Targeting of Metabolism in Cancer. Acta Biomaterialia. PMID 31958597 DOI: 10.1016/J.Actbio.2020.01.019 |
0.364 |
|
| 2020 |
Sun J, Chen Y, Xu J, Song X, Wan Z, Du Y, Ma W, Li X, Zhang L, Li S. High Loading of Hydrophobic and Hydrophilic Agents via Small Immunostimulatory Carrier for Enhanced Tumor Penetration and Combinational Therapy. Theranostics. 10: 1136-1150. PMID 31938056 DOI: 10.7150/Thno.38287 |
0.408 |
|
| 2019 |
Lu J, Zhao W, Huang Y, Liu H, Marquez R, Gibbs RB, Li J, Venkataramanan R, Xu L, Li S, Li S. Correction to "Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier". Molecular Pharmaceutics. PMID 31397164 DOI: 10.1021/Acs.Molpharmaceut.9B00818 |
0.673 |
|
| 2019 |
Liu H, Marquez RT, Wu X, Li K, Vadlamani S, Li S, Wang Y, Xu L, Wu D. A non-intrusive evaluation method for tumor-targeting characteristics of nanomedicines based on in vivo near-infrared fluorescence imaging. Journal of Materials Chemistry. B. 7: 4751-4757. PMID 31389969 DOI: 10.1039/C9Tb00882A |
0.303 |
|
| 2019 |
Xu J, Sun J, Ho PY, Luo Z, Ma W, Zhao W, Rathod SB, Fernandez CA, Venkataramanan R, Xie W, Yu AM, Li S. Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis. Biomaterials. 210: 25-40. PMID 31054369 DOI: 10.1016/J.Biomaterials.2019.04.025 |
0.311 |
|
| 2019 |
Wan Z, Sun J, Xu J, Moharil P, Chen J, Xu J, Zhu J, Li J, Huang Y, Xu P, Ma X, Xie W, Lu B, Li S. Dual Functional Immunostimulatory Polymeric Prodrug Carrier with Pendent Indoximod for Enhanced Cancer Immunochemotherapy. Acta Biomaterialia. PMID 30930305 DOI: 10.1016/J.Actbio.2019.03.048 |
0.398 |
|
| 2018 |
Chen Y, Sun J, Huang Y, Liu Y, Liang L, Yang D, Lu B, Li S. Targeted Codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against Cancer lung metastasis. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30308300 DOI: 10.1016/J.Nano.2018.09.005 |
0.37 |
|
| 2018 |
Xu J, Zhao W, Sun J, Huang Y, Wang P, Venkataramanan R, Yang D, Ma X, Rana A, Li S. Novel glucosylceramide synthase inhibitor based prodrug copolymer micelles for delivery of anticancer agents. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30223045 DOI: 10.1016/J.Jconrel.2018.09.011 |
0.356 |
|
| 2018 |
Chen Y, Sun J, Huang Y, Lu B, Li S. Improved Cancer Immunochemotherapy via Optimal Co-delivery of Chemotherapeutic and Immunomodulatory Agents. Molecular Pharmaceutics. PMID 30222360 DOI: 10.1021/Acs.Molpharmaceut.8B00717 |
0.395 |
|
| 2018 |
Li Z, Sun J, Huang Y, Liu Y, Xu J, Chen Y, Liang L, Li J, Liao Q, Li S, Zhou K. A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin. Frontiers in Pharmacology. 9: 781. PMID 30154714 DOI: 10.3389/Fphar.2018.00781 |
0.443 |
|
| 2018 |
Epperly MW, Wipf P, Fisher R, Franicola D, Beumer J, Li S, Brand RM, Falo LD, Erdos G, Greenberger JS. Evaluation of Different Formulations and Routes for the Delivery of the Ionizing Radiation Mitigator GS-Nitroxide (JP4-039). In Vivo (Athens, Greece). 32: 1009-1023. PMID 30150422 DOI: 10.21873/Invivo.11341 |
0.306 |
|
| 2018 |
Wang Y, Wang Z, Xu J, Li J, Li S, Zhang M, Yang D. Systematic identification of non-coding pharmacogenomic landscape in cancer. Nature Communications. 9: 3192. PMID 30093685 DOI: 10.1038/S41467-018-05495-9 |
0.326 |
|
| 2018 |
Sun J, Sun L, Li J, Xu J, Wan Z, Ouyang Z, Liang L, Li S, Zeng D. A Multi-Functional Polymeric Carrier for Simultaneous Positron Emission Tomography Imaging and Combination Therapy. Acta Biomaterialia. PMID 29885530 DOI: 10.1016/J.Actbio.2018.06.010 |
0.346 |
|
| 2018 |
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, Xie W, Yang D. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell. PMID 29622465 DOI: 10.1016/J.Ccell.2018.03.006 |
0.33 |
|
| 2018 |
Bi Y, Shi X, Zhu J, Guan X, Garbacz WG, Huang Y, Gao L, Yan J, Xu M, Ren S, Ren S, Liu Y, Ma X, Li S, Xie W. Regulation of Cholesterol Sulfotransferase SULT2B1b by HNF4α Constitutes a Negative Feedback Control of Hepatic Gluconeogenesis. Molecular and Cellular Biology. PMID 29378829 DOI: 10.1128/Mcb.00654-17 |
0.305 |
|
| 2017 |
Xu J, Sun J, Wang P, Ma X, Li S. Pendant HDAC Inhibitor SAHA Derivatized Polymer as a Novel Prodrug Micellar Carrier for Anticancer Drugs. Journal of Drug Targeting. 1-32. PMID 29251528 DOI: 10.1080/1061186X.2017.1419355 |
0.361 |
|
| 2017 |
Steinman J, Epperly M, Hou W, Willis J, Wang H, Fisher R, Liu B, Bahar I, McCaw T, Kagan V, Bayir H, Yu J, Wipf P, Li S, Huq MS, et al. Improved Total-Body Irradiation Survival by Delivery of Two Radiation Mitigators that Target Distinct Cell Death Pathways. Radiation Research. PMID 29140165 DOI: 10.1667/Rr14787.1 |
0.311 |
|
| 2017 |
Zhai Q, Chen Y, Xu J, Huang Y, Sun J, Liu Y, Zhang X, Li S, Tang S. Lymphoma immunochemotherapy: targeted delivery of doxorubicin via a dual functional nanocarrier. Molecular Pharmaceutics. PMID 28850241 DOI: 10.1021/Acs.Molpharmaceut.7B00606 |
0.379 |
|
| 2017 |
Sun JJ, Chen YC, Huang YX, Zhao WC, Liu YH, Venkataramanan R, Lu BF, Li S. Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier. Acta Pharmacologica Sinica. PMID 28504251 DOI: 10.1038/Aps.2017.44 |
0.396 |
|
| 2017 |
Sun J, Liu Y, Chen Y, Zhao W, Zhai Q, Rathod S, Huang Y, Tang S, Kwon YT, Fernandez C, Venkataramanan R, Li S. Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 258: 43-55. PMID 28501705 DOI: 10.1016/J.Jconrel.2017.05.006 |
0.378 |
|
| 2017 |
Xu J, Zhang X, Chen Y, Huang Y, Wang P, Wei Y, Ma X, Li S. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel. Molecular Pharmaceutics. 14: 31-41. PMID 28043124 DOI: 10.1021/Acs.Molpharmaceut.6B00581 |
0.337 |
|
| 2016 |
Chen Y, Xia R, Huang Y, Zhao W, Li J, Zhang X, Wang P, Venkataramanan R, Fan J, Xie W, Ma X, Lu B, Li S. An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy. Nature Communications. 7: 13443. PMID 27819653 DOI: 10.1038/Ncomms13443 |
0.388 |
|
| 2016 |
Wei Y, Tang C, Sant V, Li S, Poloyac SM, Xie W. A Molecular Aspect in the Regulation of Drug Metabolism: Does PXR-Induced Enzyme Expression Always Lead to Functional Changes in Drug Metabolism? Current Pharmacology Reports. 2: 187-192. PMID 27795941 DOI: 10.1007/S40495-016-0062-1 |
0.316 |
|
| 2016 |
Zhao M, Huang Y, Chen Y, Xu J, Li S, Guo X. PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel. Bioconjugate Chemistry. PMID 27532881 DOI: 10.1021/Acs.Bioconjchem.6B00415 |
0.421 |
|
| 2016 |
Sun J, Chen Y, Li K, Huang Y, Fu X, Zhang X, Zhao W, Wei Y, Xu L, Zhang P, Venkataramanan R, Li S. A Prodrug Micellar Carrier Assembled from Polymers with Pendant Farnesyl Thiosalicylic Acid Moieties for Improved Delivery of Paclitaxel. Acta Biomaterialia. PMID 27422196 DOI: 10.1016/J.Actbio.2016.07.014 |
0.335 |
|
| 2016 |
Zeng YQ, Cao RY, Yang JL, Li XZ, Li S, Zhong W. Design, synthesis and biological evaluation of novel HSP70 inhibitors: N, N'-disubstituted thiourea derivatives. European Journal of Medicinal Chemistry. 119: 83-95. PMID 27155465 DOI: 10.1016/j.ejmech.2016.04.042 |
0.463 |
|
| 2016 |
Zhang X, Huang Y, Li S. Improved delivery of anticancer agents via a dual function nanocarrier Nanomedicine: Nanotechnology, Biology and Medicine. 12: 452-453. DOI: 10.1016/J.Nano.2015.12.014 |
0.34 |
|
| 2015 |
Li S, Chen SJ, Chen Y. An ab initio investigation on the ground electronic state of chlorine monoxide and its singly charged cation and anion. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 152: 453-460. PMID 26247329 DOI: 10.1016/j.saa.2015.07.100 |
0.562 |
|
| 2015 |
Zhang P, Li J, Ghazwani M, Zhao W, Huang Y, Zhang X, Venkataramanan R, Li S. Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy. Biomaterials. 67: 104-114. PMID 26210177 DOI: 10.1016/J.Biomaterials.2015.07.027 |
0.382 |
|
| 2015 |
Lu J, Liu C, Wang P, Ghazwani M, Xu J, Huang Y, Ma X, Zhang P, Li S. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin. Biomaterials. 62: 176-87. PMID 26057133 DOI: 10.1016/J.Biomaterials.2015.05.046 |
0.694 |
|
| 2015 |
Zhang P, Huang Y, Kwon YT, Li S. PEGylated Fmoc-Amino Acid Conjugates as Effective Nanocarriers for Improved Drug Delivery. Molecular Pharmaceutics. 12: 1680-90. PMID 25816914 DOI: 10.1021/Acs.Molpharmaceut.5B00157 |
0.397 |
|
| 2015 |
Cheng Q, Inaba Y, Lu P, Xu M, He J, Zhao Y, Guo GL, Kuruba R, de la Vega R, Evans RW, Li S, Xie W. Chronic activation of FXR in transgenic mice caused perinatal toxicity and sensitized mice to cholesterol toxicity. Molecular Endocrinology (Baltimore, Md.). 29: 571-82. PMID 25719402 DOI: 10.1210/Me.2014-1337 |
0.311 |
|
| 2015 |
Zhang X, Huang Y, Ghazwani M, Zhang P, Li J, Thorne SH, Li S. Tunable pH-Responsive Polymeric Micelle for Cancer Treatment Acs Macro Letters. 4: 620-623. DOI: 10.1021/Acsmacrolett.5B00165 |
0.32 |
|
| 2014 |
Lu J, Zhao W, Liu H, Marquez R, Huang Y, Zhang Y, Li J, Xie W, Venkataramanan R, Xu L, Li S. An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 272-86. PMID 25456831 DOI: 10.1016/J.Jconrel.2014.10.016 |
0.727 |
|
| 2014 |
Zhang X, Huang Y, Zhao W, Liu H, Marquez R, Lu J, Zhang P, Zhang Y, Li J, Gao X, Venkataramanan R, Xu L, Li S. Targeted delivery of anticancer agents via a dual function nanocarrier with an interfacial drug-interactive motif. Biomacromolecules. 15: 4326-35. PMID 25325795 DOI: 10.1021/Bm501339J |
0.719 |
|
| 2014 |
Lu J, Zhao W, Huang Y, Liu H, Marquez R, Gibbs RB, Li J, Venkataramanan R, Xu L, Li S, Li S. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Molecular Pharmaceutics. 11: 4164-78. PMID 25265550 DOI: 10.1021/Mp500389V |
0.734 |
|
| 2014 |
Zhang Y, Huang Y, Zhao W, Lu J, Zhang P, Zhang X, Li J, Gao X, Venkataramanan R, Li S. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. The Aaps Journal. 16: 1282-91. PMID 25193267 DOI: 10.1208/S12248-014-9651-2 |
0.728 |
|
| 2014 |
Zhang X, Liu K, Huang Y, Xu J, Li J, Ma X, Li S. Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel. Bioconjugate Chemistry. 25: 1689-96. PMID 25121577 DOI: 10.1021/Bc500292J |
0.383 |
|
| 2014 |
Zhang X, Huang Y, Zhao W, Chen Y, Zhang P, Li J, Venkataramanan R, Li S. PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel. Molecular Pharmaceutics. 11: 2807-14. PMID 24987803 DOI: 10.1021/Mp500181X |
0.449 |
|
| 2014 |
Zhang P, Huang Y, Liu H, Marquez RT, Lu J, Zhao W, Zhang X, Gao X, Li J, Venkataramanan R, Xu L, Li S. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel. Biomaterials. 35: 7146-56. PMID 24856103 DOI: 10.1016/J.Biomaterials.2014.04.108 |
0.724 |
|
| 2014 |
Chen Y, Zhang X, Lu J, Huang Y, Li J, Li S. Targeted delivery of curcumin to tumors via PEG-derivatized FTS-based micellar system. The Aaps Journal. 16: 600-8. PMID 24706375 DOI: 10.1208/S12248-014-9595-6 |
0.721 |
|
| 2014 |
Zhang Y, Huang Y, Li S. Polymeric micelles: nanocarriers for cancer-targeted drug delivery. Aaps Pharmscitech. 15: 862-71. PMID 24700296 DOI: 10.1208/S12249-014-0113-Z |
0.404 |
|
| 2014 |
Zhang X, Huang Y, Li S. Nanomicellar carriers for targeted delivery of anticancer agents. Therapeutic Delivery. 5: 53-68. PMID 24341817 DOI: 10.4155/Tde.13.135 |
0.391 |
|
| 2014 |
Zhang P, Lu J, Huang Y, Zhao W, Zhang Y, Zhang X, Li J, Venkataramanan R, Gao X, Li S. Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier. The Aaps Journal. 16: 114-24. PMID 24281690 DOI: 10.1208/S12248-013-9536-9 |
0.719 |
|
| 2013 |
Lu J, Huang Y, Zhao W, Chen Y, Li J, Gao X, Venkataramanan R, Li S. Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. Molecular Pharmaceutics. 10: 2880-90. PMID 23768151 DOI: 10.1021/Mp300729Y |
0.691 |
|
| 2013 |
Zhang P, Huang Y, Makhov AM, Gao X, Zhang P, Li S. Characterization of spherulites as a lipidic carrier for low and high molecular weight agents. Pharmaceutical Research. 30: 1525-35. PMID 23579481 DOI: 10.1007/S11095-013-0990-Y |
0.318 |
|
| 2013 |
Zhang X, Lu J, Huang Y, Zhao W, Chen Y, Li J, Gao X, Venkataramanan R, Sun M, Stolz DB, Zhang L, Li S. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Bioconjugate Chemistry. 24: 464-72. PMID 23425093 DOI: 10.1021/Bc300608H |
0.707 |
|
| 2013 |
Gao X, Huang Y, Makhov AM, Epperly M, Lu J, Grab S, Zhang P, Rohan L, Xie XQ, Wipf P, Greenberger J, Li S. Nanoassembly of surfactants with interfacial drug-interactive motifs as tailor-designed drug carriers. Molecular Pharmaceutics. 10: 187-98. PMID 23244299 DOI: 10.1021/Mp300319M |
0.705 |
|
| 2013 |
Lu J, Huang Y, Zhao W, Marquez RT, Meng X, Li J, Gao X, Venkataramanan R, Wang Z, Li S. PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. Biomaterials. 34: 1591-600. PMID 23182923 DOI: 10.1016/J.Biomaterials.2012.10.073 |
0.703 |
|
| 2013 |
Li J, Ghazwani M, Zhang Y, Lu J, Li J, Fan J, Gandhi CR, Li S. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. Journal of Hepatology. 58: 522-8. PMID 23178710 DOI: 10.1016/J.Jhep.2012.11.011 |
0.631 |
|
| 2012 |
Zhang Y, Huang Y, Zhang P, Gao X, Gibbs RB, Li S. Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells. International Journal of Nanomedicine. 7: 4473-85. PMID 22927761 DOI: 10.2147/Ijn.S31981 |
0.328 |
|
| 2012 |
Huang Y, Lu J, Gao X, Li J, Zhao W, Sun M, Stolz DB, Venkataramanan R, Rohan LC, Li S. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjugate Chemistry. 23: 1443-51. PMID 22681537 DOI: 10.1021/Bc3000468 |
0.712 |
|
| 2010 |
Zhai Y, Wada T, Zhang B, Khadem S, Ren S, Kuruba R, Li S, Xie W. A functional cross-talk between liver X receptor-α and constitutive androstane receptor links lipogenesis and xenobiotic responses. Molecular Pharmacology. 78: 666-74. PMID 20592274 DOI: 10.1124/Mol.110.064618 |
0.308 |
|
| 2009 |
Kuruba R, Wilson A, Gao X, Li S. Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation. The Aaps Journal. 11: 23-30. PMID 19132538 DOI: 10.1208/S12248-008-9073-0 |
0.325 |
|
| 2006 |
Holder E, Griesenbach U, Li S, Huang L, Rogers DF, Jeffery PK, Geddes DM, Alton EW. Intravenously administered oligonucleotides can be delivered to conducting airway epithelium via the bronchial circulation. Gene Therapy. 13: 1628-38. PMID 16791284 DOI: 10.1038/Sj.Gt.3302811 |
0.474 |
|
| 2005 |
Wilson A, He F, Li J, Ma Z, Pitt B, Li S. Targeted delivery of therapeutic oligonucleotides to pulmonary circulation. Advances in Genetics. 54: 21-41. PMID 16096006 DOI: 10.1016/S0065-2660(05)54002-1 |
0.331 |
|
| 2005 |
Wilson A, Zhou W, Champion HC, Alber S, Tang ZL, Kennel S, Watkins S, Huang L, Pitt B, Li S. Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 510-8. PMID 15953766 DOI: 10.1016/J.Ymthe.2005.04.005 |
0.494 |
|
| 2005 |
Ma Z, Li J, He F, Wilson A, Pitt B, Li S. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochemical and Biophysical Research Communications. 330: 755-9. PMID 15809061 DOI: 10.1016/J.Bbrc.2005.03.041 |
0.336 |
|
| 2005 |
Wilson AS, Kennel SJ, Huang L, Pitt BR, Li S. 586. Novel Lipidic Vectors for Targeted Delivery of Functional Oligonucleotides to Pulmonary Endothelium Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.126 |
0.349 |
|
| 2004 |
Banerjee R, Tyagi P, Li S, Huang L. Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells. International Journal of Cancer. Journal International Du Cancer. 112: 693-700. PMID 15382053 DOI: 10.1002/Ijc.20452 |
0.532 |
|
| 2004 |
Yang L, Li J, Zhou W, Yuan X, Li S. Targeted delivery of antisense oligodeoxynucleotides to folate receptor-overexpressing tumor cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 95: 321-31. PMID 14980780 DOI: 10.1016/J.Jconrel.2003.11.021 |
0.396 |
|
| 2003 |
Zhang JS, Li S, Huang L. Cationic liposome-protamine-DNA complexes for gene delivery. Methods in Enzymology. 373: 332-42. PMID 14714413 DOI: 10.1016/S0076-6879(03)73021-3 |
0.519 |
|
| 2003 |
Sheikh M, Feig J, Gee B, Li S, Savva M. In vitro lipofection with novel series of symmetric 1,3-dialkoylamidopropane-based cationic surfactants containing single primary and tertiary amine polar head groups. Chemistry and Physics of Lipids. 124: 49-61. PMID 12787943 DOI: 10.1016/S0009-3084(03)00033-1 |
0.645 |
|
| 2003 |
Yuan X, Ma Z, Zhou W, Niidome T, Alber S, Huang L, Watkins S, Li S. Lipid-mediated delivery of peptide nucleic acids to pulmonary endothelium. Biochemical and Biophysical Research Communications. 302: 6-11. PMID 12593839 DOI: 10.1016/S0006-291X(03)00058-5 |
0.496 |
|
| 2003 |
Wilson A, Pitt B, Li S. Complex roles of CpG in liposomal delivery of DNA and oligonucleotides. Bioscience Reports. 22: 309-22. PMID 12428907 DOI: 10.1023/A:1020146924504 |
0.302 |
|
| 2002 |
Zhou W, Yuan X, Wilson A, Yang L, Mokotoff M, Pitt B, Li S. Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles. Bioconjugate Chemistry. 13: 1220-5. PMID 12440856 DOI: 10.1021/Bc025569Z |
0.369 |
|
| 2002 |
Ueno NT, Bartholomeusz C, Xia W, Anklesaria P, Bruckheimer EM, Mebel E, Paul R, Li S, Yo GH, Huang L, Hung MC. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene. Cancer Research. 62: 6712-6. PMID 12438271 |
0.471 |
|
| 2002 |
Ma Z, Zhang J, Alber S, Dileo J, Negishi Y, Stolz D, Watkins S, Huang L, Pitt B, Li S. Lipid-mediated delivery of oligonucleotide to pulmonary endothelium. American Journal of Respiratory Cell and Molecular Biology. 27: 151-9. PMID 12151306 DOI: 10.1165/Ajrcmb.27.2.4653 |
0.493 |
|
| 2002 |
Tan Y, Whitmore M, Li S, Frederik P, Huang L. LPD nanoparticles--novel nonviral vector for efficient gene delivery. Methods in Molecular Medicine. 69: 73-81. PMID 11987799 DOI: 10.1385/1-59259-141-8:073 |
0.487 |
|
| 2002 |
Whitmore MM, Li S, Falo L, Huang L. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunology, Immunotherapy : Cii. 50: 503-14. PMID 11776372 DOI: 10.1007/S002620100227 |
0.481 |
|
| 2001 |
Whitemore M, Li S, Huang L. Liposome vectors for in vivo gene delivery. Current Protocols in Human Genetics. Unit 12.8. PMID 18428252 DOI: 10.1002/0471142905.Hg1208S20 |
0.516 |
|
| 2001 |
Li S, Ma Z. Nonviral gene therapy. Current Gene Therapy. 1: 201-226. PMID 12108955 DOI: 10.2174/1566523013348814 |
0.304 |
|
| 2001 |
Hofman C, Dileo J, Li Z, Li S, Huang L. Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity. Gene Therapy. 8: 71-74. PMID 11402304 DOI: 10.1038/Sj.Gt.3301373 |
0.499 |
|
| 2001 |
Tan Y, Liu F, Li Z, Li S, Huang L. Sequential Injection of Cationic Liposome and Plasmid DNA Effectively Transfects the Lung with Minimal Inflammatory Toxicity Molecular Therapy. 3: 673-682. PMID 11356072 DOI: 10.1006/Mthe.2001.0311 |
0.503 |
|
| 2000 |
Zhou R, Zhou Y, Chen D, Li S, Haug A. Effects of soaking temperature and soaking time during preparation of water extract of tea on anticlastogenicity against environmental tobacco smoke in the sister-chromatid exchange assay. Toxicology Letters. 115: 23-32. PMID 10817628 DOI: 10.1016/S0378-4274(00)00171-5 |
0.491 |
|
| 2000 |
Zhou R, Zhou Y, Li S, Haug A. Effect of environmental tobacco smoke on intracellular free calcium of boar sperm incubated in seminal plasma. Toxicology Letters. 114: 135-41. PMID 10713478 DOI: 10.1016/S0378-4274(99)00291-X |
0.474 |
|
| 2000 |
Li S, Tan Y, Viroonchatapan E, Pitt BR, Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. American Journal of Physiology. Lung Cellular and Molecular Physiology. 278: L504-11. PMID 10710522 DOI: 10.1152/Ajplung.2000.278.3.L504 |
0.52 |
|
| 2000 |
Zhou R, Li S, Zhou Y, Haug A. Comparison of environmental tobacco smoke concentrations and mutagenicity for several indoor environments. Mutation Research. 465: 191-200. PMID 10708986 DOI: 10.1016/S1383-5718(99)00229-6 |
0.466 |
|
| 2000 |
Li B, Li S, Tan Y, Stolz DB, Watkins SC, Block LH, Huang L. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. Journal of Pharmaceutical Sciences. 89: 355-364. PMID 10707016 DOI: 10.1002/(Sici)1520-6017(200003)89:3<355::Aid-Jps7>3.0.Co;2-H |
0.513 |
|
| 2000 |
Li S, Huang L. Nonviral gene therapy: promises and challenges. Gene Therapy. 7: 31-34. PMID 10680013 DOI: 10.1038/Sj.Gt.3301110 |
0.436 |
|
| 1999 |
Tan Y, Li S, Pitt BR, Huang L. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Human Gene Therapy. 10: 2153-61. PMID 10498247 DOI: 10.1089/10430349950017149 |
0.508 |
|
| 1999 |
Li S, Tseng WC, Stolz DB, Wu SP, Watkins SC, Huang L. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Therapy. 6: 585-594. PMID 10476218 DOI: 10.1038/Sj.Gt.3300865 |
0.502 |
|
| 1999 |
Brisson M, He Y, Li S, Yang JP, Huang L. A novel T7 RNA polymerase autogene for efficient cytoplasmic expression of target genes Gene Therapy. 6: 263-270. PMID 10435111 DOI: 10.1038/Sj.Gt.3300827 |
0.453 |
|
| 1999 |
Li S, Wu SP, Whitmore M, Loeffert EJ, Wang L, Watkins SC, Pitt BR, Huang L. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. The American Journal of Physiology. 276: L796-804. PMID 10330036 DOI: 10.1152/Ajplung.1999.276.5.L796 |
0.522 |
|
| 1999 |
Nikitin AY, Juárez-Pérez MI, Li S, Huang L, Lee WH. RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. Proceedings of the National Academy of Sciences of the United States of America. 96: 3916-21. PMID 10097138 DOI: 10.1073/Pnas.96.7.3916 |
0.309 |
|
| 1998 |
Li S, Rizzo MA, Bhattacharya S, Huang L. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery Gene Therapy. 5: 930-937. PMID 9813664 DOI: 10.1038/Sj.Gt.3300683 |
0.536 |
|
| 1998 |
Li S, Deshmukh HM, Huang L. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells. Pharmaceutical Research. 15: 1540-5. PMID 9794495 DOI: 10.1023/A:1011946915209 |
0.473 |
|
| 1998 |
Li S, Huang L. Targeted Delivery of Antisense Oligodeoxynucleotides Formulated in a Novel Lipidic Vector Journal of Liposome Research. 8: 239-250. DOI: 10.3109/08982109809035529 |
0.504 |
|
| 1997 |
Li S, Brisson M, He Y, Huang L. Delivery of a PCR amplified DNA fragment into cells: A model for using synthetic genes for gene therapy Gene Therapy. 4: 449-454. PMID 9274722 DOI: 10.1038/Sj.Gt.3300413 |
0.49 |
|
| 1997 |
Huang L, Li S. Liposomal gene delivery: a complex package. Nature Biotechnology. 15: 620-1. PMID 9219259 DOI: 10.1038/Nbt0797-620 |
0.498 |
|
| 1997 |
Li S, Huang L. Protamine Sulfate Provides Enhanced and Reproducible Intravenous Gene Transfer by Cationic Liposome/DNA Complex Journal of Liposome Research. 7: 207-219. DOI: 10.3109/08982109709035496 |
0.516 |
|
| 1997 |
Huang L, Li S. Intravenous Delivery of Genes: Introduction to the Forum Journal of Liposome Research. 7: vii-xi. DOI: 10.3109/08982109709035491 |
0.499 |
|
| 1997 |
Li S, Huang L. Targeted Delivery of Antisense Oligodeoxynucleotides by LPDII Journal of Liposome Research. 7: 63-75. DOI: 10.3109/08982109709035482 |
0.524 |
|
| 1996 |
Li S, Huang L. Lipidic Supramolecular Assemblies for Gene Transfer Journal of Liposome Research. 6: 589-608. DOI: 10.3109/08982109609031138 |
0.498 |
|
| 1996 |
Li S, Gao X, Son K, Sorgi F, Hofland H, Huang L. DC-Chol lipid system in gene transfer Journal of Controlled Release. 39: 373-381. DOI: 10.1016/0168-3659(95)00167-0 |
0.761 |
|
| Show low-probability matches. |